Co-Diagnostics's accounts payable is $1.1M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), CODX shows a accounts payable of $1.1M. That compares with $1.6M in the prior-year period — down 34.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CODX's accounts payable is now $1.1M (was $1.6M) — a 34.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Co-Diagnostics is outperforming or lagging.
Tracking CODX's accounts payable over time shows whether Co-Diagnostics is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1M That compares with $1.6M in the prior-year period — down 34.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this accounts payable page, Stockcircle has Co-Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.1M) with ownership activity and broader fundamentals.
Co-Diagnostics's accounts payable is $1.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.